| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |